Siliq
PHONETIC PRONUNCIATION: Siliq
Description
Siliq: A Comprehensive Guide to Uses, Dosage, Demographic, Side Effects, Interactions, and Generic Options Psoriasis is a chronic skin condition that affects millions of people worldwide. Characterized by scaly, raised patches of skin, psoriasis can be unsightly and uncomfortable. Siliq is a medication used to treat moderate to severe cases of psoriasis in adult patients. In this article, we will examine the uses, dosage, demographic, side effects, interactions, and generic options of Siliq. Uses of Siliq Siliq contains the active ingredient brodalumab, which is a monoclonal antibody that inhibits the activity of interleukin-17 receptor A. This action reduces the inflammation in the skin that causes psoriasis. Doctors may prescribe Siliq to treat patients with moderate to severe plaque psoriasis who have failed to respond to other treatments or have experienced adverse reactions to those treatments. Dosage of Siliq Siliq is administered as a subcutaneous injection once every two weeks for the first three doses, then once every four weeks thereafter. The recommended dosage is 210 mg for the first three doses, followed by 210 mg once every four weeks. Patients should receive the injections from a healthcare professional. Self-administration is not recommended. Demographic Siliq is intended for adult patients only and should not be used in children under 18 years old. It is also not recommended for use in pregnant or breastfeeding women. Patients with a history of depression or suicidal thoughts should not use Siliq, as it has been shown to increase the risk of these conditions. Side Effects of Siliq Like all medications, Siliq can cause side effects. The most common side effects include headache, joint pain, fatigue, diarrhea, and nausea. More serious side effects may include depression, suicidal thoughts, infections, and hypersensitivity reactions. Patients should report any side effects to their healthcare provider. Interactions of Siliq Siliq can interact with other medications and substances. Patients should inform their healthcare providers of all medications, supplements, and herbal remedies they are taking. Siliq may interact with immunosuppressants, which may increase the risk of infection. Generic Options of Siliq Brodalumab is the generic name for Siliq and is available under the brand name Kyntheum. Kyntheum is currently approved in Europe and other regions but not yet available in the United States. Patients may wish to discuss the availability of Kyntheum with their healthcare provider. Conclusion Siliq is a medication used to treat moderate to severe plaque psoriasis in adult patients. It is administered as a subcutaneous injection once every two weeks for the first three doses, then once every four weeks thereafter. Patients with a history of depression or suicidal thoughts should not use Siliq. Like all medications, Siliq can cause side effects, and patients should report any side effects to their healthcare provider. Brodalumab is the generic name for Siliq and is available under the brand name Kyntheum in some regions. Patients may wish to discuss the availability of Kyntheum with their healthcare provider.
Faq for Siliq
Siliq (brodalumab) is a prescription medication used for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy.
Siliq works by specifically binding to a protein called interleukin-17 receptor A (IL-17RA), which blocks the inflammatory response associated with psoriasis.
Siliq is given as a subcutaneous injection (under the skin) that can be self-administered after proper training or administered by a healthcare professional.
The common side effects of Siliq include joint pain, headache, fatigue, diarrhea, injection site reactions, throat pain, nausea, muscle pain, and flu-like symptoms.
Siliq should not be used during pregnancy as it may harm the unborn baby. Also, it is not known if the drug passes into breast milk, so breastfeeding should be avoided during treatment.
The effectiveness of Siliq varies among individuals, but improvement in psoriasis symptoms can be observed within 4 to 12 weeks of treatment.
Yes, Siliq can be used in combination with certain other psoriasis medications, but this should be discussed with a healthcare provider.
Insurance coverage for Siliq may vary depending on the specific plan. It is advisable to contact the insurance provider or consult with a pharmacist to determine coverage options.
The duration of Siliq treatment depends on individual response and the prescribing healthcare provider's recommendations. It may be continued for as long as necessary to maintain disease control.
Yes, Siliq carries warnings of the risk of suicidal thoughts or behavior and depression. Patients should be monitored for signs of worsening depression or suicidal thoughts during treatment. Other precautions include the risk of infections and allergic reactions.